Loading...
4728 logo

Sunmax Biotechnology Co., Ltd.TPEX:4728 Stock Report

Market Cap NT$20.7b
Share Price
NT$380.00
NT$351.4
8.1% overvalued intrinsic discount
1Y-4.5%
7D-0.9%
1D
Portfolio Value
View

Sunmax Biotechnology Co., Ltd.

TPEX:4728 Stock Report

Market Cap: NT$20.7b

Sunmax Biotechnology (4728) Stock Overview

A biomedical company, develops, manufactures, and markets biomedical grade collagen and skin care product in Taiwan and Mainland China. More details

4728 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance3/6
Financial Health6/6
Dividends1/6

4728 Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

Sunmax Biotechnology Co., Ltd. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Sunmax Biotechnology
Historical stock prices
Current Share PriceNT$380.00
52 Week HighNT$450.00
52 Week LowNT$350.00
Beta-0.12
1 Month Change-1.94%
3 Month Change-2.56%
1 Year Change-4.52%
3 Year Change68.14%
5 Year Change424.86%
Change since IPO837.81%

Recent News & Updates

Recent updates

Analysis Article Feb 28

Investors Who Bought Sunmax Biotechnology (GTSM:4728) Shares Three Years Ago Are Now Up 166%

It might seem bad, but the worst that can happen when you buy a stock (without leverage) is that its share price goes...
Analysis Article Feb 02

Is Sunmax Biotechnology Co., Ltd. (GTSM:4728) The Right Choice For A Smart Dividend Investor?

Today we'll take a closer look at Sunmax Biotechnology Co., Ltd. ( GTSM:4728 ) from a dividend investor's perspective...
Analysis Article Dec 20

Sunmax Biotechnology Co., Ltd.'s (GTSM:4728) Stock Is Going Strong: Is the Market Following Fundamentals?

Most readers would already be aware that Sunmax Biotechnology's (GTSM:4728) stock increased significantly by 12% over...
Analysis Article Nov 24

Is Sunmax Biotechnology's (GTSM:4728) Share Price Gain Of 152% Well Earned?

The most you can lose on any stock (assuming you don't use leverage) is 100% of your money. But in contrast you can...

Shareholder Returns

4728TW BiotechsTW Market
7D-0.9%5.0%5.7%
1Y-4.5%35.0%108.6%

Return vs Industry: 4728 underperformed the TW Biotechs industry which returned 35% over the past year.

Return vs Market: 4728 underperformed the TW Market which returned 108.6% over the past year.

Price Volatility

Is 4728's price volatile compared to industry and market?
4728 volatility
4728 Average Weekly Movement2.3%
Biotechs Industry Average Movement6.0%
Market Average Movement6.2%
10% most volatile stocks in TW Market12.3%
10% least volatile stocks in TW Market2.5%

Stable Share Price: 4728 has not had significant price volatility in the past 3 months compared to the TW market.

Volatility Over Time: 4728's weekly volatility (2%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2001n/aMing Yi Linwww.sunmaxbiotech.com

Sunmax Biotechnology Co., Ltd., a biomedical company, develops, manufactures, and markets biomedical grade collagen and skin care product in Taiwan and Mainland China. The company offers dermal fillers, including Sunmax Deusaderm VITAL and Sunmax Deusaderm LIDO Injectable Collagen Gel with Lidocaine. The company was founded in 2001 and is headquartered in Tainan City, Taiwan.

Sunmax Biotechnology Co., Ltd. Fundamentals Summary

How do Sunmax Biotechnology's earnings and revenue compare to its market cap?
4728 fundamental statistics
Market capNT$20.70b
Earnings (TTM)NT$724.03m
Revenue (TTM)NT$2.04b
28.6x
P/E Ratio
10.2x
P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
4728 income statement (TTM)
RevenueNT$2.04b
Cost of RevenueNT$443.32m
Gross ProfitNT$1.59b
Other ExpensesNT$869.47m
EarningsNT$724.03m

Last Reported Earnings

Mar 31, 2026

Next Earnings Date

n/a

Earnings per share (EPS)13.29
Gross Margin78.23%
Net Profit Margin35.55%
Debt/Equity Ratio0%

How did 4728 perform over the long term?

See historical performance and comparison

Dividends

3.2%
Current Dividend Yield
91%
Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/06/01 08:59
End of Day Share Price 2026/06/01 00:00
Earnings2026/03/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Sunmax Biotechnology Co., Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.